APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metformin Hydrochloride Sustained-release Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Metformin Hydrochloride Sustained-release Drug Market Analysis and Forecast 2026-2032

22 December 2025208 pages

Choose your research edition.

Industry ResearchMetformin Hydrochloride Sustained-release Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Metformin Hydrochloride Sustained-release Drug Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Metformin Hydrochloride Sustained-release Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metformin Hydrochloride Sustained-release Drug Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Metformin Hydrochloride Sustained-release Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Metformin Hydrochloride Sustained-release Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Metformin Hydrochloride Sustained-release Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Metformin Hydrochloride Sustained-release Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Metformin Hydrochloride Sustained-release Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Metformin Hydrochloride Sustained-release Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Metformin Hydrochloride Sustained-release Drug include Apotex, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Viatris, Jingfeng Pharmaceutical Group, Beijing Shengyong Pharmaceutical, SinocorpPharma, Tianan Pharmaceutical and Jiangsu Deyuan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Metformin Hydrochloride Sustained-release Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Metformin Hydrochloride Sustained-release Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Metformin Hydrochloride Sustained-release Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metformin Hydrochloride Sustained-release Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Metformin Hydrochloride Sustained-release Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Metformin Hydrochloride Sustained-release Drug sales, projected growth trends, production technology, application and end-user industry.

Metformin Hydrochloride Sustained-release Drug Segment by Company

Apotex

Dr. Reddy's Laboratories

Sun Pharmaceutical Industries

Viatris

Jingfeng Pharmaceutical Group

Beijing Shengyong Pharmaceutical

SinocorpPharma

Tianan Pharmaceutical

Jiangsu Deyuan Pharmaceutical

Merck

Qingdao Huanghai Pharmaceutical

Shanghai Pharmaceuticals

CSPC

Teva Pharmaceuticals

Topfond Pharmaceutical

CTTQ

Chongqing Conquer Pharmaceutical

Metformin Hydrochloride Sustained-release Drug Segment by Type

Tablet

Capsule

Metformin Hydrochloride Sustained-release Drug Segment by Application

Hospital

Clinic

Other

Metformin Hydrochloride Sustained-release Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride Sustained-release Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride Sustained-release Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride Sustained-release Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Metformin Hydrochloride Sustained-release Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Metformin Hydrochloride Sustained-release Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metformin Hydrochloride Sustained-release Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Manufacturers Table 3. Capsule Major Manufacturers Table 4. Global Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Metformin Hydrochloride Sustained-release Drug Industry Trends Table 9. Metformin Hydrochloride Sustained-release Drug Industry Drivers Table 10. Metformin Hydrochloride Sustained-release Drug Industry Opportunities and Challenges Table 11. Metformin Hydrochloride Sustained-release Drug Industry Restraints Table 12. Global Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Metformin Hydrochloride Sustained-release Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Metformin Hydrochloride Sustained-release Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region (2021-2026) Table 16. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region (2027-2032) Table 17. Global Metformin Hydrochloride Sustained-release Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2021-2026) & (k units) Table 19. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2027-2032) & (k units) Table 20. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Region (2021-2026) Table 21. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Region (2027-2032) Table 22. Global Metformin Hydrochloride Sustained-release Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Metformin Hydrochloride Sustained-release Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Metformin Hydrochloride Sustained-release Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Metformin Hydrochloride Sustained-release Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Metformin Hydrochloride Sustained-release Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Metformin Hydrochloride Sustained-release Drug Manufacturers, Product Type & Application Table 30. Global Metformin Hydrochloride Sustained-release Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Metformin Hydrochloride Sustained-release Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Metformin Hydrochloride Sustained-release Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type (2021-2026) Table 37. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type (2027-2032) Table 38. Global Metformin Hydrochloride Sustained-release Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 40. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (k units) Table 41. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type (2021-2026) Table 42. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type (2027-2032) Table 43. Global Metformin Hydrochloride Sustained-release Drug Price by Type (2021-2026) & (US$/unit) Table 44. Global Metformin Hydrochloride Sustained-release Drug Price by Type (2027-2032) & (US$/unit) Table 45. Global Metformin Hydrochloride Sustained-release Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application (2021-2026) Table 49. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application (2027-2032) Table 50. Global Metformin Hydrochloride Sustained-release Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 52. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (k units) Table 53. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application (2021-2026) Table 54. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application (2027-2032) Table 55. Global Metformin Hydrochloride Sustained-release Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Metformin Hydrochloride Sustained-release Drug Price by Application (2027-2032) & (US$/unit) Table 57. Apotex Company Information Table 58. Apotex Business Overview Table 59. Apotex Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Apotex Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 61. Apotex Recent Development Table 62. Dr. Reddy's Laboratories Company Information Table 63. Dr. Reddy's Laboratories Business Overview Table 64. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 66. Dr. Reddy's Laboratories Recent Development Table 67. Sun Pharmaceutical Industries Company Information Table 68. Sun Pharmaceutical Industries Business Overview Table 69. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 71. Sun Pharmaceutical Industries Recent Development Table 72. Viatris Company Information Table 73. Viatris Business Overview Table 74. Viatris Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Viatris Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 76. Viatris Recent Development Table 77. Jingfeng Pharmaceutical Group Company Information Table 78. Jingfeng Pharmaceutical Group Business Overview Table 79. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 81. Jingfeng Pharmaceutical Group Recent Development Table 82. Beijing Shengyong Pharmaceutical Company Information Table 83. Beijing Shengyong Pharmaceutical Business Overview Table 84. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 86. Beijing Shengyong Pharmaceutical Recent Development Table 87. SinocorpPharma Company Information Table 88. SinocorpPharma Business Overview Table 89. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 91. SinocorpPharma Recent Development Table 92. Tianan Pharmaceutical Company Information Table 93. Tianan Pharmaceutical Business Overview Table 94. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 96. Tianan Pharmaceutical Recent Development Table 97. Jiangsu Deyuan Pharmaceutical Company Information Table 98. Jiangsu Deyuan Pharmaceutical Business Overview Table 99. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 101. Jiangsu Deyuan Pharmaceutical Recent Development Table 102. Merck Company Information Table 103. Merck Business Overview Table 104. Merck Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Merck Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 106. Merck Recent Development Table 107. Qingdao Huanghai Pharmaceutical Company Information Table 108. Qingdao Huanghai Pharmaceutical Business Overview Table 109. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 111. Qingdao Huanghai Pharmaceutical Recent Development Table 112. Shanghai Pharmaceuticals Company Information Table 113. Shanghai Pharmaceuticals Business Overview Table 114. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 116. Shanghai Pharmaceuticals Recent Development Table 117. CSPC Company Information Table 118. CSPC Business Overview Table 119. CSPC Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. CSPC Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 121. CSPC Recent Development Table 122. Teva Pharmaceuticals Company Information Table 123. Teva Pharmaceuticals Business Overview Table 124. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 126. Teva Pharmaceuticals Recent Development Table 127. Topfond Pharmaceutical Company Information Table 128. Topfond Pharmaceutical Business Overview Table 129. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 131. Topfond Pharmaceutical Recent Development Table 132. CTTQ Company Information Table 133. CTTQ Business Overview Table 134. CTTQ Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. CTTQ Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 136. CTTQ Recent Development Table 137. Chongqing Conquer Pharmaceutical Company Information Table 138. Chongqing Conquer Pharmaceutical Business Overview Table 139. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio Table 141. Chongqing Conquer Pharmaceutical Recent Development Table 142. North America Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Metformin Hydrochloride Sustained-release Drug Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 145. North America Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (k units) Table 146. North America Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2021-2026) & (US$/unit) Table 147. North America Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2027-2032) & (US$/unit) Table 148. North America Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Metformin Hydrochloride Sustained-release Drug Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 151. North America Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (k units) Table 152. North America Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2021-2026) & (US$/unit) Table 153. North America Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2027-2032) & (US$/unit) Table 154. North America Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 158. North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 159. North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2027-2032) & (k units) Table 160. North America Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2021-2026) & (US$/unit) Table 161. North America Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2027-2032) & (US$/unit) Table 162. United States Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 163. Canada Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 164. Mexico Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 165. Europe Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Metformin Hydrochloride Sustained-release Drug Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 168. Europe Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (k units) Table 169. Europe Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2021-2026) & (US$/unit) Table 170. Europe Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2027-2032) & (US$/unit) Table 171. Europe Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Metformin Hydrochloride Sustained-release Drug Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 174. Europe Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (k units) Table 175. Europe Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2021-2026) & (US$/unit) Table 176. Europe Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2027-2032) & (US$/unit) Table 177. Europe Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 181. Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 182. Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2027-2032) & (k units) Table 183. Europe Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2021-2026) & (US$/unit) Table 184. Europe Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2027-2032) & (US$/unit) Table 185. Germany Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 186. France Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 187. U.K. Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 188. Italy Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 189. Russia Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 190. Spain Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 191. Netherlands Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 192. Switzerland Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 193. Sweden Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 194. Poland Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 195. China Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2026) & (US$ Million) Table 196. China Metformin Hydrochloride Sustained-release Drug Revenue by Type (2027-2032) & (US$ Million) Table 197. China Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 198. China Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (k units) Table 199. China Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2021-2026) & (US$/unit) Table 200. China Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2027-2032) & (US$/unit) Table 201. China Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2026) & (US$ Million) Table 202. China Metformin Hydrochloride Sustained-release Drug Revenue by Application (2027-2032) & (US$ Million) Table 203. China Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 204. China Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (k units) Table 205. China Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2021-2026) & (US$/unit) Table 206. China Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2027-2032) & (US$/unit) Table 207. Asia Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Metformin Hydrochloride Sustained-release Drug Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 210. Asia Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (k units) Table 211. Asia Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2021-2026) & (US$/unit) Table 212. Asia Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2027-2032) & (US$/unit) Table 213. Asia Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2026) & (US$ Million) Table 214. Asia Metformin Hydrochloride Sustained-release Drug Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 216. Asia Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (k units) Table 217. Asia Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2021-2026) & (US$/unit) Table 218. Asia Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2027-2032) & (US$/unit) Table 219. Asia Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Asia Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Asia Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 223. Asia Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 224. Asia Metformin Hydrochloride Sustained-release Drug Sales by Country (2027-2032) & (k units) Table 225. Asia Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2021-2026) & (US$/unit) Table 226. Asia Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2027-2032) & (US$/unit) Table 227. Japan Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 228. South Korea Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 229. India Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 230. Australia Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 231. Taiwan Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 232. Southeast Asia Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 233. SAMEA Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2026) & (US$ Million) Table 234. SAMEA Metformin Hydrochloride Sustained-release Drug Revenue by Type (2027-2032) & (US$ Million) Table 235. SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2026) & (k units) Table 236. SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Type (2027-2032) & (k units) Table 237. SAMEA Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2021-2026) & (US$/unit) Table 238. SAMEA Metformin Hydrochloride Sustained-release Drug Sales Price by Type (2027-2032) & (US$/unit) Table 239. SAMEA Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2026) & (US$ Million) Table 240. SAMEA Metformin Hydrochloride Sustained-release Drug Revenue by Application (2027-2032) & (US$ Million) Table 241. SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2026) & (k units) Table 242. SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Application (2027-2032) & (k units) Table 243. SAMEA Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2021-2026) & (US$/unit) Table 244. SAMEA Metformin Hydrochloride Sustained-release Drug Sales Price by Application (2027-2032) & (US$/unit) Table 245. SAMEA Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. SAMEA Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. SAMEA Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 249. SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Country (2021-2026) & (k units) Table 250. SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Country (2027-2032) & (k units) Table 251. SAMEA Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2021-2026) & (US$/unit) Table 252. SAMEA Metformin Hydrochloride Sustained-release Drug Sales Price by Country (2027-2032) & (US$/unit) Table 253. Brazil Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 254. Argentina Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 255. Chile Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 256. Colombia Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 257. Peru Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 258. Saudi Arabia Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 259. Israel Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 260. UAE Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 261. Turkey Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 262. Iran Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 263. Egypt Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Metformin Hydrochloride Sustained-release Drug Distributors List Table 267. Metformin Hydrochloride Sustained-release Drug Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Metformin Hydrochloride Sustained-release Drug Image Figure 2. Global Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metformin Hydrochloride Sustained-release Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Capsule Image Figure 6. Global Metformin Hydrochloride Sustained-release Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Metformin Hydrochloride Sustained-release Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Metformin Hydrochloride Sustained-release Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Metformin Hydrochloride Sustained-release Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Metformin Hydrochloride Sustained-release Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Metformin Hydrochloride Sustained-release Drug Sales (2021-2032) & (k units) Figure 17. Global Metformin Hydrochloride Sustained-release Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Metformin Hydrochloride Sustained-release Drug Sales YoY (2021-2032) & (k units) Figure 20. Europe Metformin Hydrochloride Sustained-release Drug Sales YoY (2021-2032) & (k units) Figure 21. China Metformin Hydrochloride Sustained-release Drug Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Metformin Hydrochloride Sustained-release Drug Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales YoY (2021-2032) & (k units) Figure 24. Global Metformin Hydrochloride Sustained-release Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Metformin Hydrochloride Sustained-release Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type (2021-2032) Figure 33. Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application (2021-2032) Figure 39. North America Metformin Hydrochloride Sustained-release Drug Revenue Share by Type (2021-2032) Figure 40. North America Metformin Hydrochloride Sustained-release Drug Sales Share by Type (2021-2032) Figure 41. North America Metformin Hydrochloride Sustained-release Drug Revenue Share by Application (2021-2032) Figure 42. North America Metformin Hydrochloride Sustained-release Drug Sales Share by Application (2021-2032) Figure 43. North America Metformin Hydrochloride Sustained-release Drug Revenue Share by Country (2021-2032) Figure 44. North America Metformin Hydrochloride Sustained-release Drug Sales Share by Country (2021-2032) Figure 45. Europe Metformin Hydrochloride Sustained-release Drug Revenue Share by Type (2021-2032) Figure 46. Europe Metformin Hydrochloride Su

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Apotex
  • Dr. Reddy's Laboratories
  • Sun Pharmaceutical Industries
  • Viatris
  • Jingfeng Pharmaceutical Group
  • Beijing Shengyong Pharmaceutical
  • SinocorpPharma
  • Tianan Pharmaceutical
  • Jiangsu Deyuan Pharmaceutical
  • Merck
  • Qingdao Huanghai Pharmaceutical
  • Shanghai Pharmaceuticals
  • CSPC
  • Teva Pharmaceuticals
  • Topfond Pharmaceutical
  • CTTQ
  • Chongqing Conquer Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Metformin Hydrochloride Sustained-release Drug Market by Type
  3. 1.2.1 Global Metformin Hydrochloride Sustained-release Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Capsule
  6. 1.3 Metformin Hydrochloride Sustained-release Drug Market by Application
  7. 1.3.1 Global Metformin Hydrochloride Sustained-release Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Metformin Hydrochloride Sustained-release Drug Market Dynamics
  1. 2.1 Metformin Hydrochloride Sustained-release Drug Industry Trends
  2. 2.2 Metformin Hydrochloride Sustained-release Drug Industry Drivers
  3. 2.3 Metformin Hydrochloride Sustained-release Drug Industry Opportunities and Challenges
  4. 2.4 Metformin Hydrochloride Sustained-release Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Metformin Hydrochloride Sustained-release Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Region
  3. 3.2.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Metformin Hydrochloride Sustained-release Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Metformin Hydrochloride Sustained-release Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Metformin Hydrochloride Sustained-release Drug Sales by Region
  9. 3.4.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Manufacturers
  2. 4.1.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Metformin Hydrochloride Sustained-release Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Manufacturers
  6. 4.2.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Metformin Hydrochloride Sustained-release Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Metformin Hydrochloride Sustained-release Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Metformin Hydrochloride Sustained-release Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Metformin Hydrochloride Sustained-release Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Metformin Hydrochloride Sustained-release Drug Manufacturers, Product Type & Application
  13. 4.7 Global Metformin Hydrochloride Sustained-release Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Metformin Hydrochloride Sustained-release Drug Market CR5 and HHI
  16. 4.8.2 2025 Metformin Hydrochloride Sustained-release Drug Tier 1, Tier 2, and Tier 3
5 Metformin Hydrochloride Sustained-release Drug Market by Type
  1. 5.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Type
  2. 5.1.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Type
  6. 5.2.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Metformin Hydrochloride Sustained-release Drug Price by Type
6 Metformin Hydrochloride Sustained-release Drug Market by Application
  1. 6.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Application
  2. 6.1.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Application
  6. 6.2.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Metformin Hydrochloride Sustained-release Drug Price by Application
7 Company Profiles
  1. 7.1 Apotex
  2. 7.1.1 Apotex Company Information
  3. 7.1.2 Apotex Business Overview
  4. 7.1.3 Apotex Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Apotex Metformin Hydrochloride Sustained-release Drug Product Portfolio
  6. 7.1.5 Apotex Recent Developments
  7. 7.2 Dr. Reddy's Laboratories
  8. 7.2.1 Dr. Reddy's Laboratories Company Information
  9. 7.2.2 Dr. Reddy's Laboratories Business Overview
  10. 7.2.3 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product Portfolio
  12. 7.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 7.3 Sun Pharmaceutical Industries
  14. 7.3.1 Sun Pharmaceutical Industries Company Information
  15. 7.3.2 Sun Pharmaceutical Industries Business Overview
  16. 7.3.3 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product Portfolio
  18. 7.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 7.4 Viatris
  20. 7.4.1 Viatris Company Information
  21. 7.4.2 Viatris Business Overview
  22. 7.4.3 Viatris Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Viatris Metformin Hydrochloride Sustained-release Drug Product Portfolio
  24. 7.4.5 Viatris Recent Developments
  25. 7.5 Jingfeng Pharmaceutical Group
  26. 7.5.1 Jingfeng Pharmaceutical Group Company Information
  27. 7.5.2 Jingfeng Pharmaceutical Group Business Overview
  28. 7.5.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product Portfolio
  30. 7.5.5 Jingfeng Pharmaceutical Group Recent Developments
  31. 7.6 Beijing Shengyong Pharmaceutical
  32. 7.6.1 Beijing Shengyong Pharmaceutical Company Information
  33. 7.6.2 Beijing Shengyong Pharmaceutical Business Overview
  34. 7.6.3 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  36. 7.6.5 Beijing Shengyong Pharmaceutical Recent Developments
  37. 7.7 SinocorpPharma
  38. 7.7.1 SinocorpPharma Company Information
  39. 7.7.2 SinocorpPharma Business Overview
  40. 7.7.3 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product Portfolio
  42. 7.7.5 SinocorpPharma Recent Developments
  43. 7.8 Tianan Pharmaceutical
  44. 7.8.1 Tianan Pharmaceutical Company Information
  45. 7.8.2 Tianan Pharmaceutical Business Overview
  46. 7.8.3 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  48. 7.8.5 Tianan Pharmaceutical Recent Developments
  49. 7.9 Jiangsu Deyuan Pharmaceutical
  50. 7.9.1 Jiangsu Deyuan Pharmaceutical Company Information
  51. 7.9.2 Jiangsu Deyuan Pharmaceutical Business Overview
  52. 7.9.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  54. 7.9.5 Jiangsu Deyuan Pharmaceutical Recent Developments
  55. 7.10 Merck
  56. 7.10.1 Merck Company Information
  57. 7.10.2 Merck Business Overview
  58. 7.10.3 Merck Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Merck Metformin Hydrochloride Sustained-release Drug Product Portfolio
  60. 7.10.5 Merck Recent Developments
  61. 7.11 Qingdao Huanghai Pharmaceutical
  62. 7.11.1 Qingdao Huanghai Pharmaceutical Company Information
  63. 7.11.2 Qingdao Huanghai Pharmaceutical Business Overview
  64. 7.11.3 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  66. 7.11.5 Qingdao Huanghai Pharmaceutical Recent Developments
  67. 7.12 Shanghai Pharmaceuticals
  68. 7.12.1 Shanghai Pharmaceuticals Company Information
  69. 7.12.2 Shanghai Pharmaceuticals Business Overview
  70. 7.12.3 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio
  72. 7.12.5 Shanghai Pharmaceuticals Recent Developments
  73. 7.13 CSPC
  74. 7.13.1 CSPC Company Information
  75. 7.13.2 CSPC Business Overview
  76. 7.13.3 CSPC Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CSPC Metformin Hydrochloride Sustained-release Drug Product Portfolio
  78. 7.13.5 CSPC Recent Developments
  79. 7.14 Teva Pharmaceuticals
  80. 7.14.1 Teva Pharmaceuticals Company Information
  81. 7.14.2 Teva Pharmaceuticals Business Overview
  82. 7.14.3 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio
  84. 7.14.5 Teva Pharmaceuticals Recent Developments
  85. 7.15 Topfond Pharmaceutical
  86. 7.15.1 Topfond Pharmaceutical Company Information
  87. 7.15.2 Topfond Pharmaceutical Business Overview
  88. 7.15.3 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  90. 7.15.5 Topfond Pharmaceutical Recent Developments
  91. 7.16 CTTQ
  92. 7.16.1 CTTQ Company Information
  93. 7.16.2 CTTQ Business Overview
  94. 7.16.3 CTTQ Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CTTQ Metformin Hydrochloride Sustained-release Drug Product Portfolio
  96. 7.16.5 CTTQ Recent Developments
  97. 7.17 Chongqing Conquer Pharmaceutical
  98. 7.17.1 Chongqing Conquer Pharmaceutical Company Information
  99. 7.17.2 Chongqing Conquer Pharmaceutical Business Overview
  100. 7.17.3 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
  102. 7.17.5 Chongqing Conquer Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Metformin Hydrochloride Sustained-release Drug Market Size by Type
  2. 8.1.1 North America Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Metformin Hydrochloride Sustained-release Drug Price by Type (2021-2032)
  5. 8.2 North America Metformin Hydrochloride Sustained-release Drug Market Size by Application
  6. 8.2.1 North America Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Metformin Hydrochloride Sustained-release Drug Price by Application (2021-2032)
  9. 8.3 North America Metformin Hydrochloride Sustained-release Drug Market Size by Country
  10. 8.3.1 North America Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Metformin Hydrochloride Sustained-release Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Metformin Hydrochloride Sustained-release Drug Market Size by Type
  2. 9.1.1 Europe Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Metformin Hydrochloride Sustained-release Drug Price by Type (2021-2032)
  5. 9.2 Europe Metformin Hydrochloride Sustained-release Drug Market Size by Application
  6. 9.2.1 Europe Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Metformin Hydrochloride Sustained-release Drug Price by Application (2021-2032)
  9. 9.3 Europe Metformin Hydrochloride Sustained-release Drug Market Size by Country
  10. 9.3.1 Europe Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Metformin Hydrochloride Sustained-release Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Metformin Hydrochloride Sustained-release Drug Market Size by Type
  2. 10.1.1 China Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2032)
  4. 10.1.3 China Metformin Hydrochloride Sustained-release Drug Price by Type (2021-2032)
  5. 10.2 China Metformin Hydrochloride Sustained-release Drug Market Size by Application
  6. 10.2.1 China Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2032)
  8. 10.2.3 China Metformin Hydrochloride Sustained-release Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Metformin Hydrochloride Sustained-release Drug Market Size by Type
  2. 11.1.1 Asia Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Metformin Hydrochloride Sustained-release Drug Price by Type (2021-2032)
  5. 11.2 Asia Metformin Hydrochloride Sustained-release Drug Market Size by Application
  6. 11.2.1 Asia Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Metformin Hydrochloride Sustained-release Drug Price by Application (2021-2032)
  9. 11.3 Asia Metformin Hydrochloride Sustained-release Drug Market Size by Country
  10. 11.3.1 Asia Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Metformin Hydrochloride Sustained-release Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Metformin Hydrochloride Sustained-release Drug Market Size by Type
  2. 12.1.1 SAMEA Metformin Hydrochloride Sustained-release Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Metformin Hydrochloride Sustained-release Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Metformin Hydrochloride Sustained-release Drug Market Size by Application
  6. 12.2.1 SAMEA Metformin Hydrochloride Sustained-release Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Metformin Hydrochloride Sustained-release Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Metformin Hydrochloride Sustained-release Drug Market Size by Country
  10. 12.3.1 SAMEA Metformin Hydrochloride Sustained-release Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Metformin Hydrochloride Sustained-release Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Metformin Hydrochloride Sustained-release Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Metformin Hydrochloride Sustained-release Drug Value Chain Analysis
  2. 13.1.1 Metformin Hydrochloride Sustained-release Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Metformin Hydrochloride Sustained-release Drug Production Mode & Process
  6. 13.2 Metformin Hydrochloride Sustained-release Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Metformin Hydrochloride Sustained-release Drug Distributors
  9. 13.2.3 Metformin Hydrochloride Sustained-release Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst